Alaska Permanent Fund Corp 13D/13G Filings for Vir Biotechnology, Inc. (VIR)

Alaska Permanent Fund Corp 13D and 13G filings for Vir Biotechnology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-16
07:08 am
Sale		 2020-12-31 13G Vir Biotechnology, Inc.
VIR		 Alaska Permanent Fund Corp 3,893,040
3.060%		 -1,662,516decrease
(-29.93%)		 Filing
2020-05-07
07:04 am
Unchanged		 2020-04-14 13G Vir Biotechnology, Inc.
VIR		 Alaska Permanent Fund Corp 5,555,556
5.060%		 0
(Unchanged)		 Filing